Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 1c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• Fluence Energy, Inc. (FLNC 10K contracts of January 10 calls trade
• Teradyne (TER) 5300 contracts of October 30 weekly calls active, share price down 2.6%